
KOD
97.62 USD
-0.54%
Today
-0.49%
1D
Market is closed
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 11:00 PM
Sat
Closed
Information
Name
Kodiak Sciences Inc Leveraged
Currency
USD
Core Leverage
1:2
Plus Leverage
1:2
Max Leverage
1:10
Overnight Fees Buy (Core Leverage)
-0.0190%
Overnight Fees Sell (Core Leverage)
0.0024%
Overnight Fees Buy (Plus Leverage)
-0.0190%
Overnight Fees Sell (Plus Leverage)
0.0024%
Overnight Fees Buy (Max Leverage)
-0.0190%
Overnight Fees Sell (Max Leverage)
0.0024%
Market Cap
6.40B
Avg Daily Volume
1.76M
52 Week High
112.79 USD
52 Week Low
19.04 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01900% | $(0.190) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Top News
Kodiak_Sciences
-0.49%
JP Morgan maintains Kodiak Sciences at Overweight, raises price target to $128 from $124
tradingview.com
2d ago

Kodiak_Sciences
-0.49%
KOD: Tarcocimab advances toward filing as KSI-101’s pivotal data approach
tradingview.com
4d ago

Kodiak_Sciences
-0.49%
KOD: Zenkuda’s BLA, KSI-101’s PEAK 1 readout and accelerating KSI-501 trials define the near-term milestones
tradingview.com
5d ago

Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.

